Within the microenvironment of liver cancer cells, CENP‐F also positively correlates with inhibitory checkpoint molecules such as PD‐1, CTLA‐4, and TIM‐3, suggesting its involvement in the weakening of anti‐tumor immunity in liver cancer cells [104]. Here, HAVCR2 is linked to liver cancer.